Intrommune Therapeutics Strengthens Board of Directors with Appointments of Dr. Jonathan Rich and Hem Pandya
GlobeNewswire
NEW YORK, March 12, 2024 (GLOBE NEWSWIRE) -- Intrommune Therapeutics, Inc., a clinical-stage biotechnology company committed to..